Prognostic factor analysis of health-related quality of life data in cancer: a statistical methodological evaluation (Q33596402)

28 July 2017

title

Prognostic factor analysis of health-related quality of life data in cancer: a statistical methodological evaluation (English)

1 reference

28 July 2017

0 references

1 reference

C Gotay

1 reference

28 July 2017

Me Mauer

1 reference

28 July 2017

A Bottomley

series ordinal

1 reference

28 July 2017

C Coens

series ordinal

1 reference

28 July 2017

publication date

1 April 2008

1 reference

Expert Review of Pharmacoeconomics & Outcomes Research

28 July 2017

published in

1 reference

28 July 2017

1 reference

28 July 2017

1 reference

28 July 2017

page(s)

179-196

1 reference

Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trial

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737167.8.2.179

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.8.2.179

The challenges and achievements involved in implementing Quality of Life research in cancer clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.8.2.179

Baseline health-related quality-of-life data as prognostic factors in a phase III multicentre study of women with metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.8.2.179

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.8.2.179

Prognostic factors for patients with inoperable non-small cell lung cancer, limited disease. The importance of patients' subjective experience of disease and psychosocial well-being

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.8.2.179

Quality of life in lung cancer patients: as an important prognostic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.8.2.179

Is quality of life predictive of the survival of patients with advanced nonsmall cell lung carcinoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.8.2.179

Quality of life as a survival predictor for esophageal squamous cell carcinoma treated with radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.8.2.179

The prognostic value of quality of life scores during treatment for oesophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.8.2.179

Prognostic value of quality of life scores for time to progression (TTP) and overall survival time (OS) in advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.8.2.179

Prognostic value of quality of life scores in a trial of chemotherapy with or without interferon in patients with metastatic malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.8.2.179

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.8.2.179

Sociodemographic factors and quality of life as prognostic indicators in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.8.2.179

The prognostic significance of patient-reported outcomes in cancer clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.8.2.179

Quality of life as a predictor of cancer survival among Chinese liver and lung cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.8.2.179

Survival prediction in terminally ill cancer patients by clinical estimates, laboratory tests, and self-rated anxiety and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.8.2.179

Baseline psychosocial predictors of survival in localized melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.8.2.179

Lung cancer symptoms and pulse oximetry in the prognostic assessment of patients with lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.8.2.179

Health status measurements at diagnosis as predictors of survival among adults with brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.8.2.179

EuroQol and survival prediction in terminal cancer patients: a multicenter prospective study in hospice-palliative care units.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.8.2.179

Prognostic significance of symptoms of hospitalised advanced cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.8.2.179

Prostate-specific antigen and other prognostic factors in patients with hormone-resistant prostatic cancer undergoing experimental treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.8.2.179

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.8.2.179

Decreased quality of life and depression as predictors for shorter survival among patients with low-grade gliomas: a follow-up from 1990 to 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.8.2.179

Bias due to missing exposure data using complete-case analysis in the proportional hazards regression model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.8.2.179

Imputations of missing values in practice: results from imputations of serum cholesterol in 28 cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.8.2.179

Quality of life outcomes from a randomized phase III trial of cisplatin with or without topotecan in advanced carcinoma of the cervix: a Gynecologic Oncology Group Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.8.2.179

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.8.2.179

Quality of life evaluation in a randomised trial of chemotherapy versus bio-chemotherapy in advanced melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.8.2.179

Prognostic value of health-related quality-of-life data in predicting survival in patients with anaplastic oligodendrogliomas, from a phase III EORTC brain cancer group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.8.2.179

The prognostic value of health-related quality-of-life data in predicting survival in glioblastoma cancer patients: results from an international randomised phase III EORTC Brain Tumour and Radiation Oncology Groups, and NCIC Clinical Trials Group s

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.8.2.179

Dangers of using "optimal" cutpoints in the evaluation of prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.8.2.179

Quality of life scores: an independent prognostic variable in a general population of cancer patients receiving chemotherapy. The National Cancer Institute of Canada Clinical Trials Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.8.2.179

Psychological symptoms and disease-free and overall survival in women with stage II breast cancer. Cancer and Leukemia Group B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.8.2.179

Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.8.2.179

Cognitive function as a predictor of survival in patients with recurrent malignant glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.8.2.179

Identification and interpretation of clinical and quality of life prognostic factors for survival and response to treatment in first-line chemotherapy in advanced breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.8.2.179

Quality of life in lung cancer surgical adjuvant trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.8.2.179

Quality of life as a potential predictor for morbidity and mortality in patients with metastatic hormone-refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.8.2.179

Failure of higher-dose paclitaxel to improve outcome in patients with metastatic breast cancer: cancer and leukemia group B trial 9342.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.8.2.179

Assessing quality of life during chemotherapy for pleural mesothelioma: feasibility, validity, and results of using the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire and Lung Cancer Module

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.8.2.179

Baseline quality of life predicts survival in patients with advanced colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.8.2.179

Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer--pooled analysis from three multicenter, randomized, controlled trials using individual patient data

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.8.2.179

Early change in patient-reported health during lung cancer chemotherapy predicts clinical outcomes beyond those predicted by baseline report: results from Eastern Cooperative Oncology Group Study 5592.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.8.2.179

Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the eld

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.8.2.179

Is baseline quality of life useful for predicting survival with hormone-refractory prostate cancer? A pooled analysis of three studies of the European Organisation for Research and Treatment of Cancer Genitourinary Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.8.2.179

Prospective study of quality of life in adults with newly diagnosed high-grade gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.8.2.179

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.8.2.179

Does a patient's self-reported health-related quality of life predict survival beyond key biomedical data in advanced colorectal cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.8.2.179

A bootstrap resampling procedure for model building: Application to the cox regression model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.8.2.179

Multicollinearity in prognostic factor analyses using the EORTC QLQ-C30: identification and impact on model selection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.8.2.179

Quality of life in phase II trials: a study of methodology and predictive value in patients with advanced breast cancer treated with paclitaxel plus granulocyte colony-stimulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.8.2.179

Assessment of quality of life in the supportive care setting of the big lung trial in non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.8.2.179

Quality of life in advanced non-small-cell lung cancer: results of a Southwest Oncology Group randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.8.2.179

Descriptive and prognostic value of patient-reported outcomes: the bortezomib experience in relapsed and refractory multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.8.2.179

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.8.2.179

Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.8.2.179

21 January 2018

Identifiers

DOI

10.1586/14737167.8.2.179

1 reference

release_trhy7gwz4rbq7otnllfn37wuce

28 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/trhy7gwz4rbq7otnllfn37wuce

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference